The Latest Cardiac and Vascular News
Ticker to remain NSPR TEL AVIV, Israel, May 10, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced the Company’s shares have been approved for listing […]
SANTA CLARA, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recognized revenue of $31.9 million […]
Roxadustat net product revenue in China of $15.4 million, on a US GAAP basis Total roxadustat net sales in China of $43.5 million1 by FibroGen and the distribution entity jointly owned by FibroGen and AstraZeneca, compared to $29.2 million last quarter FDA to hold Advisory Committee Meeting on Roxadustat NDA – […]
2,100 patients enrolled in randomized controlled trial to evaluate a precision-testing pathway for suspected coronary artery disease REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced the completion of patient enrollment in the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) randomized controlled trial. Physicians from more […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the presentation of additional preclinical data from the company’s gene editing programs for the treatment of atherosclerotic cardiovascular disease (ASCVD), the most common form of cardiovascular […]
− Initiates Clinical Study of Biannual Dosing Regimen of Investigational Vutrisiran in hATTR Patients with Polyneuropathy, with Data Expected in 2022 Potentially Supporting sNDA Submission – − Introduces New ATTR Program Aimed at Achieving Annual Dosing Regimen with Highly Potent and Reversible Effects; Expected IND Filing at or Around Year-end 2022 – […]
Toloue brings deep expertise and industry acumen to lead the Company’s strategic expansion into diagnostics BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, […]
Company Expands Global Reach with Latest Endovascular Aneurysm Repair (EVAR) Technology IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a leader in the treatment of vascular disease, today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. ALTO was also recently approved for commercial sale […]
New metal-alloy scoring sheath CE Mark cleared for treatment of peripheral artery disease and end stage renal disease. PARK CITY, Utah, May 10, 2021 /PRNewswire/ — Transit Scientific announced it received CE Mark clearance in the European Union for the XO Score® Scoring Sheath Platform to facilitate dilation of stenotic material in the peripheral vasculature […]
BE’ER SHEVA, Israel, and SHENZHEN, China , May 10, 2021 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation (300633.SZ), a leading developer and manufacturer of ultrasound systems. As part of the partnership, SonoScape’s ultrasound devices will provide DiA’s ultrasound artificial intelligence analysis solutions […]
